These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 16263988)
1. Effectiveness of iron supplementation in a young child with attention-deficit/hyperactivity disorder. Konofal E; Cortese S; Lecendreux M; Arnulf I; Mouren MC Pediatrics; 2005 Nov; 116(5):e732-4. PubMed ID: 16263988 [TBL] [Abstract][Full Text] [Related]
2. Effects of iron supplementation on attention deficit hyperactivity disorder in children. Konofal E; Lecendreux M; Deron J; Marchand M; Cortese S; Zaïm M; Mouren MC; Arnulf I Pediatr Neurol; 2008 Jan; 38(1):20-6. PubMed ID: 18054688 [TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder. Biederman J; Melmed RD; Patel A; McBurnett K; Konow J; Lyne A; Scherer N; Pediatrics; 2008 Jan; 121(1):e73-84. PubMed ID: 18166547 [TBL] [Abstract][Full Text] [Related]
4. [Validation of the Turkish versions of the short-form Conners' teacher and parent rating scales]. Dereboy C; Senol S; Sener S; Dereboy F Turk Psikiyatri Derg; 2007; 18(1):48-58. PubMed ID: 17364268 [TBL] [Abstract][Full Text] [Related]
5. Iron deficiency in children with attention-deficit/hyperactivity disorder. Konofal E; Lecendreux M; Arnulf I; Mouren MC Arch Pediatr Adolesc Med; 2004 Dec; 158(12):1113-5. PubMed ID: 15583094 [TBL] [Abstract][Full Text] [Related]
6. Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder. Bangs ME; Hazell P; Danckaerts M; Hoare P; Coghill DR; Wehmeier PM; Williams DW; Moore RJ; Levine L; Pediatrics; 2008 Feb; 121(2):e314-20. PubMed ID: 18245404 [TBL] [Abstract][Full Text] [Related]
7. Serum ferritin in children with attention-deficit hyperactivity disorder. Millichap JG; Yee MM; Davidson SI Pediatr Neurol; 2006 Mar; 34(3):200-3. PubMed ID: 16504789 [TBL] [Abstract][Full Text] [Related]
8. The usefulness of Conners' Rating Scales-Revised in screening for attention deficit hyperactivity disorder in children with intellectual disabilities and borderline intelligence. Deb S; Dhaliwal AJ; Roy M J Intellect Disabil Res; 2008 Nov; 52(11):950-65. PubMed ID: 18179511 [TBL] [Abstract][Full Text] [Related]
9. Parent, teacher, child. A trilateral approach to attention deficit disorder. Cohen ML; Kelly PC; Atkinson AW Am J Dis Child; 1989 Oct; 143(10):1229-33. PubMed ID: 2801667 [TBL] [Abstract][Full Text] [Related]
10. Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents. Biederman J; Pliszka SR J Pediatr; 2008 Mar; 152(3):394-9. PubMed ID: 18280848 [TBL] [Abstract][Full Text] [Related]
11. Iron deficiency in children with attention deficit hyperactivity disorder. Lahat E; Heyman E; Livne A; Goldman M; Berkovitch M; Zachor D Isr Med Assoc J; 2011 Sep; 13(9):530-3. PubMed ID: 21991711 [TBL] [Abstract][Full Text] [Related]
12. The prevalence of attention deficit-hyperactivity disorder in children with nonmonosymptomatic nocturnal enuresis: a 4-year followup study. Baeyens D; Roeyers H; Van Erdeghem S; Hoebeke P; Vande Walle J J Urol; 2007 Dec; 178(6):2616-20. PubMed ID: 17945295 [TBL] [Abstract][Full Text] [Related]
13. Improved behavior and sleep after adenotonsillectomy in children with sleep-disordered breathing. Wei JL; Mayo MS; Smith HJ; Reese M; Weatherly RA Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):974-9. PubMed ID: 17938319 [TBL] [Abstract][Full Text] [Related]
14. Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study. Huang YS; Guilleminault C; Li HY; Yang CM; Wu YY; Chen NH Sleep Med; 2007 Jan; 8(1):18-30. PubMed ID: 17157069 [TBL] [Abstract][Full Text] [Related]
15. Impact of restless legs syndrome and iron deficiency on attention-deficit/hyperactivity disorder in children. Konofal E; Cortese S; Marchand M; Mouren MC; Arnulf I; Lecendreux M Sleep Med; 2007 Nov; 8(7-8):711-5. PubMed ID: 17644481 [TBL] [Abstract][Full Text] [Related]
16. An autonomic nervous system biofeedback modality for the treatment of attention deficit hyperactivity disorder--an open pilot study. Eisenberg J; Ben-Daniel N; Mei-Tal G; Wertman E Isr J Psychiatry Relat Sci; 2004; 41(1):45-53. PubMed ID: 15160655 [TBL] [Abstract][Full Text] [Related]
17. Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study. Dell'Agnello G; Maschietto D; Bravaccio C; Calamoneri F; Masi G; Curatolo P; Besana D; Mancini F; Rossi A; Poole L; Escobar R; Zuddas A; Eur Neuropsychopharmacol; 2009 Nov; 19(11):822-34. PubMed ID: 19716683 [TBL] [Abstract][Full Text] [Related]
18. Aspartame, behavior, and cognitive function in children with attention deficit disorder. Shaywitz BA; Sullivan CM; Anderson GM; Gillespie SM; Sullivan B; Shaywitz SE Pediatrics; 1994 Jan; 93(1):70-5. PubMed ID: 7505423 [TBL] [Abstract][Full Text] [Related]
19. Iron and zinc supplementation does not improve parent or teacher ratings of behavior in first grade Mexican children exposed to lead. Kordas K; Stoltzfus RJ; López P; Rico JA; Rosado JL J Pediatr; 2005 Nov; 147(5):632-9. PubMed ID: 16291354 [TBL] [Abstract][Full Text] [Related]
20. Comparison of parent and teacher reports of attention-deficit/hyperactivity disorder symptoms from two placebo-controlled studies of atomoxetine in children. Biederman J; Gao H; Rogers AK; Spencer TJ Biol Psychiatry; 2006 Nov; 60(10):1106-10. PubMed ID: 16806096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]